The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Graña, X., & Reddy, E. P. (1995) · PubMed · Cited by 1,139
Tsujimoto, Y., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5214 · Cited by 1,106
Berger, J., Hauber, J., Hauber, R., Geiger, R., & Cullen, B. R. (1988) · Gene · doi:10.1016/0378-1119(88)90219-3 · Cited by 667
Engineered Biosynthesis of Novel Polyketides
McDaniel, R. N., Ebert‐Khosla, S., Hopwood, D. A., & Khosla, C. (1993) · Science · doi:10.1126/science.8248802 · Cited by 472
p21--Negative Regulator of the Cell Cycle
Gartel, A. L., Serfas, M. S., & Tyner, A. L. (1996) · Experimental Biology and Medicine · doi:10.3181/00379727-213-44046 · Cited by 407
Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R., & Darlington, G. J. (1996) · Genes & Development · doi:10.1101/gad.10.7.804 · Cited by 387
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., & Vousden, K. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00418.x · Cited by 301
McDaniel, R., Ebert-Khosla, S., Hopwood, D. A., & Khosla, C. (1995) · Nature · doi:10.1038/375549a0 · Cited by 283
Minn, A. J., Boise, L. H., & Thompson, C. B. (1996) · Genes & Development · doi:10.1101/gad.10.20.2621 · Cited by 263
Huang, D. C., Cory, S., & Strasser, A. (1997) · Oncogene · doi:10.1038/sj.onc.1200848 · Cited by 242
The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo
Yang, Z.-Y., Perkins, N. D., Ohno, T., Nabel, E. G., & Nabel, G. J. (1995) · Nature Medicine · doi:10.1038/nm1095-1052 · Cited by 178
A novel cytostatic process enhances the productivity of Chinese hamster ovary cells
Fussenegger, M., Mazur, X., & Bailey, J. E. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970920)55:6<927::aid-bit10>3.0.co;2-4 · Cited by 157
Self-citationMazur, X., Fussenegger, M., Renner, W. A., & Bailey, J. E. (1998) · Biotechnology Progress · doi:10.1021/bp980062h · Cited by 115
Self-citationItoh, Y., Ueda, H., & Suzuki, E. (1995) · Biotechnology and Bioengineering · doi:10.1002/bit.260480205 · Cited by 111
Holmberg, N., Lilius, G., Bailey, J. E., & Bülow, L. (1997) · Nature Biotechnology · doi:10.1038/nbt0397-244 · Cited by 108
Self-citationSingh, R. P., Emery, A. N., & Al‐Rubeai, M. (1996) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19961005)52:1<166::aid-bit17>3.0.co;2-m · Cited by 88
Chen, J., Willingham, T., Shuford, M., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118631 · Cited by 76
Zang, M., Trautmann, H., Gandor, C. R., Messi, F., Asselbergs, F., Leist, C., Fiechter, A., & Reiser, J. (1995) · Nature Biotechnology · doi:10.1038/nbt0495-389 · Cited by 74
Renner, W. A., Lee, K. H., Vassily Hatzimanikatis, A., Bailey, J. E., & Eppenberger, H. M. (1995) · Biotechnology and Bioengineering · doi:10.1002/bit.260470409 · Cited by 63
Self-citationWill a Twist of Viral Fate Lead to a New Cancer Treatment?
Pennisi, E. (1996) · Science · doi:10.1126/science.274.5286.342 · Cited by 41
Tumor Suppressor Genes: Prospects for Cancer Therapies
Bertelsen, A. H., Beaudry, G. A., Stoller, T. J., Trotta, P. P., & Sherman, M. I. (1995) · Nature Biotechnology · doi:10.1038/nbt0295-127 · Cited by 6
Cited by
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801
Kojima, R., Bojar, D., Rizzi, G., Hamri, G. C.-E., El-Baba, M. D., Saxena, P., Ausländer, S., Tan, K. R., & Fussenegger, M. (2018) · Nature Communications · doi:10.1038/s41467-018-03733-8 · Cited by 748
“…plasmid vector (pDB60, hereinafter referred to as exosome production booster), which ensures that transfected cells receive all boosted genes at a fi xed ratio 19, 20 , produced a 15-fold to 40-fold increase (depending on cell conditions) in the luminescence signal in the supernatant (Fig.”
Self-citationA tunable synthetic mammalian oscillator
Tigges, M., Marquez-Lago, T. T., Stelling, J., & Fussenegger, M. (2009) · Nature · doi:10.1038/nature07616 · Cited by 567
Self-citationImproving lycopene production in Escherichia coli by engineering metabolic control
Farmer, W. R., & Liao, J. C. (2000) · Nature Biotechnology · doi:10.1038/75398 · Cited by 522
A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice
Ye, H., Baba, M. D.-E., Peng, R.-W., & Fussenegger, M. (2011) · Science · doi:10.1126/science.1203535 · Cited by 467
Self-citation
Metadata
- Authors
- Fussenegger, M., Schlatter, S., Dätwyler, D., Mazur, X., & Bailey, J. E.
- Venue
- Nature Biotechnology
- Published
- 1998-05
- Volume
- 16
- Issue
- 5
- Pages
- 468-472
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2006906242
- Cited by
- 269
- References
- 33
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.